Skip to main content

Table 6 Assessment of quality of evidence of risk and prognostic factors by the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system

From: A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease

GRADE factors

Risk factorsa

Analysisb

Phase

Study limitations

Inconsistencyc

Indirectness

Publication bias

Imprecision

Moderate/large effect size

Dose response gradient

Overall quality

Outcome: all-cause mortality

Age

Uni

1

+

−

−

+

−

−

−

Low

Multi

1

+

N/A

−

+

−

−

−

Very low

DLCO

Uni

1

+

+

−

+

−

+

−

Very Low

Multi

1

+

−

−

+

−

−

−

Very low

GRADE factors

Prognostic factorsa

Analysisb

Phase

Study limitations

Inconsistencyc

Indirectness

Publication bias

Imprecision

Moderate/large effect size

Dose response gradient

Overall quality

Outcome: all-cause mortality

PaO2/FiO2

Uni

1

+

−

−

+

−

−

−

Very low

Multi

1

+

N/A

−

+

−

−

−

Very low

  1. DLCO, diffusing capacity of the lung for carbon monoxide; PaO2/FiO2, partial pressure of arterial oxygen/fraction of inspired oxygen ratio
  2. aA total of two risk factors and one prognostic factor of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease were identified based on consistent and statistically significant results in multivariate analyses among clinical information that were reported by at least three studies
  3. b ‘Uni’ indicating univariate analysis while ‘Multi’ indicating multivariate analysis
  4. cN/A indicating not applicable due to only one study available